Vu Quan Anh

Vu Quan Anh is listed in filings as Chief Financial Officer at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 29, 2025, including purchase activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Mar 5, 2025 to Dec 29, 2025. Reported amounts are shown as $104.9K to $773.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.